S'abonner

Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1? production - 30/05/13

Doi : 10.1016/j.jaci.2012.07.043 
Laeticia Kolly, PhD a, , , Nathalie Busso, PhD a, , Annette von Scheven-Gete, MD b, Nathaliane Bagnoud, MSc a, Isabelle Moix, PhD d, Dirk Holzinger, MD c, Gregoire Simon, MSc a, Annette Ives, PhD a, Greta Guarda, PhD e, Alexander So, MD a, Michael A. Morris, MD d, , Michaël Hofer, MD b, ,
a Rheumatology Service, DAL, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland 
b Pediatric Rheumatology Romande Unit, Department of Pediatrics, Lausanne University Hospital, University of Lausanne, and Department of Pediatrics, Geneva University Hospital, Geneva, Switzerland 
c Institute of Immunology, University of Münster and Department of General Pediatrics, University Children's Hospital Münster, Münster, Germany 
d Genetic Medicine Service, Geneva University Hospital, Geneva, Switzerland 
e Biochemistry Institute, University of Lausanne, Lausanne, Switzerland 

Corresponding author: Michaël Hofer, MD, Pediatric Rheumatology Romande, Service de Pédiatrie, CHUV, 1011 Lausanne, Switzerland.

Abstract

Background

The exact pathogenesis of the pediatric disorder periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome is unknown.

Objectives

We hypothesized that PFAPA might be due to dysregulated monocyte IL-1β production linked to genetic variants in proinflammatory genes.

Methods

Fifteen patients with PFAPA syndrome were studied during and outside a febrile episode. Hematologic profile, inflammatory markers, and cytokine levels were measured in the blood. The capacity of LPS-stimulated PBMCs and monocytes to secrete IL-1β was assessed by using ELISA, and active IL-1β secretion was visualized by means of Western blotting. Real-time quantitative PCR was performed to assess cytokine gene expression. DNA was screened for variants of the MEFV, TNFRSF1A, MVK, and NLRP3 genes in a total of 57 patients with PFAPA syndrome.

Results

During a febrile attack, patients with PFAPA syndrome revealed significantly increased neutrophil counts, erythrocyte sedimentation rates, and C-reactive protein, serum amyloid A, myeloid-related protein 8/14, and S100A12 levels compared with those seen outside attacks. Stimulated PBMCs secreted significantly more IL-1β during an attack (during a febrile episode, 575 ± 88 pg/mL; outside a febrile episode, 235 ± 56 pg/mL; P < .001), and this was in the mature active p17 form. IL-1β secretion was inhibited by ZYVAD, a caspase inhibitor. Similar results were found for stimulated monocytes (during a febrile episode, 743 ± 183 pg/mL; outside a febrile episode, 227 ± 92 pg/mL; P < .05). Genotyping identified variants in 15 of 57 patients, with 12 NLRP3 variants, 1 TNFRSF1A variant, 4 MEFV variants, and 1 MVK variant.

Conclusion

Our data strongly suggest that IL-1β monocyte production is dysregulated in patients with PFAPA syndrome. Approximately 20% of them were found to have NLRP3 variants, suggesting that inflammasome-related genes might be involved in this autoinflammatory syndrome.

Le texte complet de cet article est disponible en PDF.

Key words : Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome, recurrent fever, autoinflammatory disease, interleukine-1β, inflammasome

Abbreviations used : AID, CAPS, IL-1Ra, IP-10, MCP, MRP, PFAPA, PFAPA-IN, PFAPA-OUT, SoJIA


Plan


 Supported by a grant from the Swiss National Science Foundation (FN 310030-130085/1), the Novartis Foundation, the Jean and Linette Warnery Foundation, and the German Ministry of Education and Research (BMBF project AID-NET).
 Disclosure of potential conflict of interest: N. Busso has received grants from the Swiss National Science Foundation. I. Moix has received grants from Novartis. D. Holzinger has received grants from Bundesministerium für Bildung und Forschung. G. Guarda is employed by and has received grants from the University of Lausanne. A. So serves on advisory boards for Novartis AG and Menarini, has received grants from the Swiss National Foundation, has received payment for lectures/service on speakers' bureaus from Menarini, and has received payment for development of educational presentations from Novartis. M. A. Morris has received grants from Novartis. M. Hofer has received grants from the Novartis Foundation, has board membership with Novartis and Bristol-Myers-Squibb, and has received travel expenses from Pfizer. The rest of the authors declare that they have no relevant conflicts of interest.


© 2012  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 6

P. 1635-1643 - juin 2013 Retour au numéro
Article précédent Article précédent
  • Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis
  • Elizabeth P. Sampaio, Amy P. Hsu, Joseph Pechacek, Hannelore I. Bax, Dalton L. Dias, Michelle L. Paulson, Prabha Chandrasekaran, Lindsey B. Rosen, Daniel S. Carvalho, Li Ding, Donald C. Vinh, Sarah K. Browne, Shrimati Datta, Joshua D. Milner, Douglas B. Kuhns, Debra A. Long Priel, Mohammed A. Sadat, Michael Shiloh, Brendan De Marco, Michael Alvares, Jason W. Gillman, Vivek Ramarathnam, Maite de la Morena, Liliana Bezrodnik, Ileana Moreira, Gulbu Uzel, Daniel Johnson, Christine Spalding, Christa S. Zerbe, Henry Wiley, David E. Greenberg, Susan E. Hoover, Sergio D. Rosenzweig, John N. Galgiani, Steven M. Holland
| Article suivant Article suivant
  • Compartmentalized chemokine-dependent regulatory T-cell inhibition of allergic pulmonary inflammation
  • Roshi Afshar, James P. Strassner, Edward Seung, Benjamin Causton, Josalyn L. Cho, R. Scott Harris, Daniel L. Hamilos, Benjamin D. Medoff, Andrew D. Luster

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.